In the BioHarmony Drug Report Database

"Preview" Icon

Fluvoxamine

Luvox (fluvoxamine) is a small molecule pharmaceutical. Fluvoxamine was first approved as Luvox on 1994-12-05. It is used to treat depressive disorder, obsessive-compulsive disorder, and panic disorder in the USA. The pharmaceutical is active against sodium-dependent serotonin transporter. In addition, it is known to target sigma non-opioid intracellular receptor 1.

 

Trade Name

 

Luvox
 

Common Name

 

fluvoxamine
 

ChEMBL ID

 

CHEMBL814
 

Indication

 

depressive disorder, obsessive-compulsive disorder, panic disorder
 

Drug Class

 

Selective serotonin reuptake inhibitor (SSRI)

Image (chem structure or protein)

Fluvoxamine structure rendering